Since Jun 03, 2009
Cell Culture Discussion Group
137 2062
Tue November 15th, 2016
Live Cell Encapsulation Technology Market Is Estimated To Grow At a High Rate in Coming Years
Download FREE PDF Brochure @ Cell encapsulation technology enables to overcome the existing issue of graft rejection in tissue engineering applications. It helps to minimize the requirement for long-term use of immuno-suppressive drugs after an organ transplant in order to control side effects. This technology is also known as Cell-in-a-Box. It enables to encapsulate cells in cellulose based, beads, with a semipermeable membrane that allow nutrients and waste product exchange, however, retains the cells within the beads. Cell-in-a-Box has been showing great promise in the areas of diabetes, cancer, and research associated with drug delivery. The global live cell encapsulation technology market is estimated to grow at a high rate during the forecast period. A number of factors such as increasing incidence of various types of cancers (such as pancreatic, breast, and brain), rising prevalence of diabetes, and rising adoption of cell encapsulation technology to develop treatments for cancer and diabetes are fuelling the growth of the global live cell encapsulation technology market. However, lack of clinical-grade polymers; production of uniform capsules; ethical, political, and regulatory issues; and other technological and biological limitations are some of the major challenges that needs to be overcome by the key players to sustain in this market.

Want to join the conversation? Login or Register!